JPMorgan Chase & Co. Purchases 738 Shares of Trupanion, Inc. (NASDAQ:TRUP)

JPMorgan Chase & Co. increased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 2.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,317 shares of the financial services provider’s stock after purchasing an additional 738 shares during the quarter. JPMorgan Chase & Co. owned 0.07% of Trupanion worth $1,189,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Wilmington Savings Fund Society FSB purchased a new position in shares of Trupanion in the 3rd quarter worth $54,000. Barclays PLC increased its holdings in Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after acquiring an additional 47,262 shares in the last quarter. DF Dent & Co. Inc. increased its holdings in Trupanion by 27.8% in the 3rd quarter. DF Dent & Co. Inc. now owns 367,871 shares of the financial services provider’s stock worth $15,443,000 after acquiring an additional 80,014 shares in the last quarter. Wellington Management Group LLP raised its stake in Trupanion by 4.4% during the 3rd quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after acquiring an additional 142,156 shares during the period. Finally, Weiss Asset Management LP purchased a new position in Trupanion during the third quarter valued at approximately $855,000.

Trupanion Price Performance

NASDAQ:TRUP opened at $48.90 on Friday. The company has a market capitalization of $2.07 billion, a P/E ratio of -152.81, a P/E/G ratio of 8.11 and a beta of 1.61. The business’s 50-day moving average is $50.60 and its 200 day moving average is $45.97. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90.

Trupanion (NASDAQ:TRUP) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.09. The firm had revenue of $327.50 million during the quarter, compared to analyst estimates of $321.79 million. Trupanion had a negative net margin of 1.08% and a negative return on equity of 4.36%. Trupanion’s revenue for the quarter was up 14.6% compared to the same quarter last year. During the same period last year, the firm posted ($0.10) earnings per share. On average, equities research analysts forecast that Trupanion, Inc. will post -0.2 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

TRUP has been the topic of several recent analyst reports. Stifel Nicolaus raised their price objective on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Northland Securities boosted their price objective on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler upgraded Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 target price for the company in a research report on Thursday. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $45.33.

Insider Transactions at Trupanion

In other Trupanion news, EVP Steve Weinrauch sold 11,916 shares of the business’s stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $53.00, for a total transaction of $631,548.00. Following the transaction, the executive vice president now owns 48,978 shares in the company, valued at $2,595,834. The trade was a 19.57 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Insiders have sold a total of 28,597 shares of company stock worth $1,522,082 in the last three months. Insiders own 5.50% of the company’s stock.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.